Page last updated: 2024-10-30

metformin and Neutropenia

metformin has been researched along with Neutropenia in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research Excerpts

ExcerptRelevanceReference
"Metformin was discontinued on day 22 (16 days after reintroduction) and neutropenia promptly reversed during next week with 1."5.35Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma. ( Hamdi, S; Huguet, F; Laporte, F; Oksman, F, 2008)
"Metformin was discontinued on day 22 (16 days after reintroduction) and neutropenia promptly reversed during next week with 1."1.35Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma. ( Hamdi, S; Huguet, F; Laporte, F; Oksman, F, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laporte, F1
Hamdi, S1
Oksman, F1
Huguet, F1

Other Studies

1 other study available for metformin and Neutropenia

ArticleYear
Auto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma.
    Pharmacy world & science : PWS, 2008, Volume: 30, Issue:4

    Topics: Aged; Antineoplastic Agents; Autoimmune Diseases; Granulocytes; Humans; Hypoglycemic Agents; Leukocy

2008